Non-muscle myosins in tumor progression, cancer cell invasion, and metastasis

Cytoskeleton

Volumn 71, Issue 8, 2014, Pages 447-463

  Ouderkirk, Jessica L ^a   Krendel, Mira ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Actin; Cancer; Metastasis; Myosin

Indexed keywords

MYOSIN; MYOSIN 1A; MYOSIN 1E; MYOSIN 1F; MYOSIN I; MYOSIN II; MYOSIN IIA; MYOSIN IX; MYOSIN VI; MYOSIN VII; MYOSIN X; MYOSIN XVIII; NON MUSCLE MYOSIN; PROTEIN P53; UNCLASSIFIED DRUG; ACTIN;

ACTIN FILAMENT; ACTIN POLYMERIZATION; APOPTOSIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL POLARITY; DISTANT METASTASIS; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; HUMAN; INFLAMMATION; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; REVIEW; SOLID MALIGNANT NEOPLASM; TUMOR ESCAPE; TUMOR GROWTH; TUMOR INVASION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; THEORETICAL MODEL;

ACTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, THEORETICAL; MYOSINS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84908051092     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.21187     Document Type: Review

References (154)

1. Adams JM, Cory S. 2007. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26(9):1324-1337.
2. Aguilar-Cuenca R, Juanes-Garcia A, Vicente-Manzanares M. 2014. Myosin II in mechanotransduction: master and commander of cell migration, morphogenesis, and cancer. Cell Mol Life Sci 71(3):479-492.
3. Ajima R, Kajiya K, Inoue T, Tani M, Shiraishi-Yamaguchi Y, Maeda M, Segawa T, Furuichi T, Sutoh K, Yokota J. 2007. HOMER2 binds MYO18B and enhances its activity to suppress anchorage independent growth. Biochem Biophys Res Commun 356(4):851-856.
4. Almagro S, Durmort C, Chervin-Petinot A, Heyraud S, Dubois M, Lambert O, Maillefaud C, Hewat E, Schaal JP, Huber P, et al. 2010. The motor protein myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts. Mol Cell Biol 30(7):1703-1717.
5. Almeida CG, Yamada A, Tenza D, Louvard D, Raposo G, Coudrier E. 2011. Myosin 1b promotes the formation of post-Golgi carriers by regulating actin assembly and membrane remodelling at the trans-Golgi network. Nat Cell Biol 13(7):779-789.
6. Arjonen A, Kaukonen R, Ivaska J. 2011. Filopodia and adhesion in cancer cell motility. Cell Adh Migr 5(5):421-430.
7. Arjonen A, Kaukonen R, Mattila E, Rouhi P, Hognas G, Sihto H, Miller BW, Morton JP, Bucher E, Taimen P, et al. 2014. Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis. J Clin Invest 124(3):1069-1082.
8. Beach JR, Hussey GS, Miller TE, Chaudhury A, Patel P, Monslow J, Zheng Q, Keri RA, Reizes O, Bresnick AR, et al. 2011. Myosin II isoform switching mediates invasiveness after TGF-beta-induced epithelial-mesenchymal transition. Proc Natl Acad Sci USA 108(44):17991-17996.
9. Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS, Canoll P. 2008. The role of myosin II in glioma invasion of the brain. Mol Biol Cell 19(8):3357-3368.
10. Berg JS, Derfler BH, Pennisi CM, Corey DP, Cheney RE. 2000. Myosin-X, a novel myosin with pleckstrin homology domains, associates with regions of dynamic actin. J Cell Sci 113(Pt 19):3439-3451.
11. Berg JS, Powell BC, Cheney RE. 2001. A millennial myosin census. Mol Biol Cell 12(4):780-794.
12. Bernardes de Jesus B, Blasco MA. 2013. Telomerase at the intersection of cancer and aging. Trends Genet 29(9):513-520.
13. Bi J, Chase SE, Pellenz CD, Kurihara H, Fanning AS, Krendel M. 2013. Myosin 1e is a component of the glomerular slit diaphragm complex that regulates actin reorganization during cell-cell contact formation in podocytes. Am J Physiol Renal Physiol 305(4):F532-F544.
14. Billington N, Wang A, Mao J, Adelstein RS, Sellers JR. 2013. Characterization of three full-length human nonmuscle myosin II paralogs. J Biol Chem 288(46):33398-33410.
15. Bohil AB, Robertson BW, Cheney RE. 2006. Myosin-X is a molecular motor that functions in filopodia formation. Proc Natl Acad Sci USA 103(33):12411-12416.
16. Bond LM, Tumbarello DA, Kendrick-Jones J, Buss F. 2013. Small-molecule inhibitors of myosin proteins. Future Med Chem 5(1):41-52.
17. Brzeska H, Hwang KJ, Korn ED. 2008. Acanthamoeba myosin IC colocalizes with phosphatidylinositol 4, 5-bisphosphate at the plasma membrane due to the high concentration of negative charge. J Biol Chem 283(46):32014-32023.
18. Buss F, Spudich G, Kendrick-Jones J. 2004. Myosin VI: cellular functions and motor properties. Annu Rev Cell Dev Biol 20:649-676.
19. Cai Y, Biais N, Giannone G, Tanase M, Jiang G, Hofman JM, Wiggins CH, Silberzan P, Buguin A, Ladoux B, et al. 2006. Nonmuscle myosin IIA-dependent force inhibits cell spreading and drives F-actin flow. Biophys J 91(10):3907-3920.
20. Campellone KG, Welch MD. 2010. A nucleator arms race: cellular control of actin assembly. Nat Rev Mol Cell Biol 11(4):237-251.
21. Cao R, Chen J, Zhang X, Zhai Y, Qing X, Xing W, Zhang L, Malik YS, Yu H, Zhu X. 2014. Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis. Br J Cancer 111(3):539-550.
22. Cervero P, Himmel M, Kruger M, Linder S. 2012. Proteomic analysis of podosome fractions from macrophages reveals similarities to spreading initiation centres. Eur J Cell Biol 91(11-12):908-922.
23. Chandhoke SK, Mooseker MS. 2012. A role for myosin IXb, a motor-RhoGAP chimera, in epithelial wound healing and tight junction regulation. Mol Biol Cell 23(13):2468-2480.
24. Cheng J, Grassart A, Drubin DG. 2012. Myosin 1E coordinates actin assembly and cargo trafficking during clathrin-mediated endocytosis. Mol Biol Cell 23(15):2891-2904.
25. Chibalina MV, Poliakov A, Kendrick-Jones J, Buss F. 2010. Myosin VI and optineurin are required for polarized EGFR delivery and directed migration. Traffic 11(10):1290-1303.
26. Conti MA, Even-Ram S, Liu C, Yamada KM, Adelstein RS. 2004. Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain II-A in mice. J Biol Chem 279(40):41263-41266.
27. Cox D, Berg JS, Cammer M, Chinegwundoh JO, Dale BM, Cheney RE, Greenberg S. 2002. Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat Cell Biol 4(7):469-477.
28. Derycke L, Stove C, Vercoutter-Edouart AS, De Wever O, Dolle L, Colpaert N, Depypere H, Michalski JC, Bracke M. 2011. The role of non-muscle myosin IIA in aggregation and invasion of human MCF-7 breast cancer cells. Int J Dev Biol 55(7-9):835-840.
29. Dippold HC, Ng MM, Farber-Katz SE, Lee SK, Kerr ML, Peterman MC, Sim R, Wiharto PA, Galbraith KA, Madhavarapu S, et al. 2009. GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell 139(2):337-351.
30. Dong W, Chen X, Chen P, Yue D, Zhu L, Fan Q. 2012. Inactivation of MYO5B promotes invasion and motility in gastric cancer cells. Dig Dis Sci 57(5):1247-1252.
31. Duhoux FP, Ameye G, Libouton JM, Bahloula K, Iossifidis S, Chantrain CF, Demoulin JB, Poirel HA. 2011. The t(11;19)(q23;p13) fusing MLL with MYO1F is recurrent in infant acute myeloid leukemias. Leuk Res 35(9):e171-e172.
32. Dunn TA, Chen S, Faith DA, Hicks JL, Platz EA, Chen Y, Ewing CM, Sauvageot J, Isaacs WB, De Marzo AM, et al. 2006. A novel role of myosin VI in human prostate cancer. Am J Pathol 169(5):1843-1854.
33. Eckert MA, Yang J. 2011. Targeting invadopodia to block breast cancer metastasis. Oncotarget 2(7):562-568.
34. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, et al. 2012. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486(7403):353-360.
35. Even-Ram S, Doyle AD, Conti MA, Matsumoto K, Adelstein RS, Yamada KM. 2007. Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk. Nat Cell Biol 9(3):299-309.
36. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. 2008. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 14(4):570-581.
37. Farber MJ, Rizaldy R, Hildebrand JD. 2011. Shroom2 regulates contractility to control endothelial morphogenesis. Mol Biol Cell 22(6):795-805.
38. Farber-Katz SE, Dippold HC, Buschman MD, Peterman MC, Xing M, Noakes CJ, Tat J, Ng MM, Rahajeng J, Cowan DM, et al. 2014. DNA damage triggers Golgi dispersal via DNA-PK and GOLPH3. Cell 156(3):413-427.
39. Feeser EA, Ignacio CM, Krendel M, Ostap EM. 2010. Myo1e binds anionic phospholipids with high affinity. Biochemistry 49(43):9353-9360.
40. Fernandez LP, Milne RL, Pita G, Floristan U, Sendagorta E, Feito M, Aviles JA, Martin-Gonzalez M, Lazaro P, Benitez J, et al. 2009. Pigmentation-related genes and their implication in malignant melanoma susceptibility. Exp Dermatol 18(7):634-642.
41. Fischer RS, Gardel M, Ma X, Adelstein RS, Waterman CM. 2009. Local cortical tension by myosin II guides 3D endothelial cell branching. Curr Biol 19(3):260-265.
42. Foth BJ, Goedecke MC, Soldati D. 2006. New insights into myosin evolution and classification. Proc Natl Acad Sci USA 103(10):3681-3686.
43. Friedl P, Gilmour D. 2009. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10(7):445-457.
44. Friedl P, Locker J, Sahai E, Segall JE. 2012. Classifying collective cancer cell invasion. Nat Cell Biol 14(8):777-783.
45. Garcia A, Coudrier E, Carboni J, Anderson J, Vandekerkhove J, Mooseker M, Louvard D, Arpin M. 1989. Partial deduced sequence of the 110-kD-calmodulin complex of the avian intestinal microvillus shows that this mechanoenzyme is a member of the myosin I family. J Cell Biol 109(6 Pt 1):2895-2903.
46. Geisbrecht ER, Montell DJ. 2002. Myosin VI is required for E-cadherin-mediated border cell migration. Nat Cell Biol 4(8):616-620.
47. Greenberg MJ, Ostap EM. 2013. Regulation and control of myosin-I by the motor and light chain-binding domains. Trends Cell Biol 23(2):81-89.
48. Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell 140(6):883-899.
49. Guzik-Lendrum S, Nagy A, Takagi Y, Houdusse A, Sellers JR. 2011. Drosophila melanogaster myosin-18 represents a highly divergent motor with actin tethering properties. J Biol Chem 286(24):21755-21766.
50. Hallett RM, Dvorkin-Gheva A, Bane A, Hassell JA. 2012. A gene signature for predicting outcome in patients with basal-like breast cancer. Sci Rep 2:227.
51. Hammer JA, III, Sellers JR. 2012. Walking to work: roles for class V myosins as cargo transporters. Nat Rev Mol Cell Biol 13(1):13-26.
52. Hammer JA, III, Wagner W. 2013. Functions of class V myosins in neurons. J Biol Chem 288(40):28428-28434.
53. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144(5):646-674.
54. Hanel W, Moll UM. 2012. Links between mutant p53 and genomic instability. J Cell Biochem 113(2):433-439.
55. Hartman MA, Spudich JA. 2012. The myosin superfamily at a glance. J Cell Sci 125(Pt 7):1627-1632.
56. Hodge T, Cope MJ. 2000. A myosin family tree. J Cell Sci 113(Pt 19):3353-3354.
57. Hokanson DE, Laakso JM, Lin T, Sept D, Ostap EM. 2006. Myo1c binds phosphoinositides through a putative pleckstrin homology domain. Mol Biol Cell 17(11):4856-4865.
58. Hsu RM, Tsai MH, Hsieh YJ, Lyu PC, Yu JS. 2010. Identification of MYO18A as a novel interacting partner of the PAK2/betaPIX/GIT1 complex and its potential function in modulating epithelial cell migration. Mol Biol Cell 21(2):287-301.
59. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, et al. 2006. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96.
60. Huang L, Muthuswamy SK. 2010. Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators. Curr Opin Genet Dev 20(1):41-50.
61. Ivkovic S, Beadle C, Noticewala S, Massey SC, Swanson KR, Toro LN, Bresnick AR, Canoll P, Rosenfeld SS. 2012. Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Mol Biol Cell 23(4):533-542.
62. Izidoro-Toledo TC, Borges AC, Araujo DD, Mazzi DP, Nascimento Junior FO, Sousa JF, Alves CP, Paiva AP, Trindade DM, Patussi EV, et al. 2013. A myosin-Va tail fragment sequesters dynein light chains leading to apoptosis in melanoma cells. Cell Death Dis 4:e547.
63. Kelley CA, Sellers JR, Gard DL, Bui D, Adelstein RS, Baines IC. 1996. Xenopus nonmuscle myosin heavy chain isoforms have different subcellular localizations and enzymatic activities. J Cell Biol 134(3):675-687.
64. Kerber ML, Cheney RE. 2011. Myosin-X: a MyTH-FERM myosin at the tips of filopodia. J Cell Sci 124(Pt 22):3733-3741.
65. Kim R, Emi M, Tanabe K. 2007. Cancer immunoediting from immune surveillance to immune escape. Immunology 121(1):1-14.
66. Kim SV, Mehal WZ, Dong X, Heinrich V, Pypaert M, Mellman I, Dembo M, Mooseker MS, Wu D, Flavell RA. 2006. Modulation of cell adhesion and motility in the immune system by Myo1f. Science 314(5796):136-139.
67. Kolega J. 1998. Cytoplasmic dynamics of myosin IIA and IIB: spatial 'sorting' of isoforms in locomoting cells. J Cell Sci 111(Pt 15):2085-2095.
68. Kravtsov DV, Caputo C, Collaco A, Hoekstra N, Egan ME, Mooseker MS, Ameen NA. 2012. Myosin Ia is required for CFTR brush border membrane trafficking and ion transport in the mouse small intestine. Traffic 13(8):1072-1082.
69. Krendel M, Mooseker MS. 2005. Myosins: tails (and heads) of functional diversity. Physiology (Bethesda) 20:239-251.
70. Krendel M, Osterweil EK, Mooseker MS. 2007. Myosin 1E interacts with synaptojanin-1 and dynamin and is involved in endocytosis. FEBS Lett 581(4):644-650.
71. Krendel M, Kim SV, Willinger T, Wang T, Kashgarian M, Flavell RA, Mooseker MS. 2009. Disruption of Myosin 1e promotes podocyte injury. J Am Soc Nephrol 20(1):86-94.
72. Lan L, Han H, Zuo H, Chen Z, Du Y, Zhao W, Gu J, Zhang Z. 2010. Upregulation of myosin Va by Snail is involved in cancer cell migration and metastasis. Int J Cancer 126(1):53-64.
73. Li ZH, Bresnick AR. 2006. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res 66(10):5173-5180.
74. Linder S, Wiesner C, Himmel M. 2011. Degrading devices: invadosomes in proteolytic cell invasion. Annu Rev Cell Dev Biol 27:185-211.
75. Lo CM, Buxton DB, Chua GC, Dembo M, Adelstein RS, Wang YL. 2004. Nonmuscle myosin IIb is involved in the guidance of fibroblast migration. Mol Biol Cell 15(3):982-989.
76. Ma X, Bao J, Adelstein RS. 2007. Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. Mol Biol Cell 18(6):2305-2312.
77. Maddugoda MP, Crampton MS, Shewan AM, Yap AS. 2007. Myosin VI and vinculin cooperate during the morphogenesis of cadherin cell cell contacts in mammalian epithelial cells. J Cell Biol 178(3):529-540.
78. Maniak M. 2001. Cell adhesion: ushering in a new understanding of myosin VII. Curr Biol 11(8):R315-R317.
79. Maravillas-Montero JL, Santos-Argumedo L. 2012. The myosin family: unconventional roles of actin-dependent molecular motors in immune cells. J Leukoc Biol 91(1):35-46.
80. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D, Brock HW, Slany R, Hess JL. 2003. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4(3):197-207.
81. Maupin P, Phillips CL, Adelstein RS, Pollard TD. 1994. Differential localization of myosin-II isozymes in human cultured cells and blood cells. J Cell Sci 107(Pt 11):3077-3090.
82. Mazerik JN, Tyska MJ. 2012. Myosin-1A targets to microvilli using multiple membrane binding motifs in the tail homology 1 (TH1) domain. J Biol Chem 287(16):13104-13115.
83. Mazzolini R, Dopeso H, Mateo-Lozano S, Chang W, Rodrigues P, Bazzocco S, Alazzouzi H, Landolfi S, Hernandez-Losa J, Andretta E, et al. 2012. Brush border myosin Ia has tumor suppressor activity in the intestine. Proc Natl Acad Sci USA 109(5):1530-1535.
84. Mazzolini R, Rodrigues P, Bazzocco S, Dopeso H, Ferreira AM, Mateo-Lozano S, Andretta E, Woerner SM, Alazzouzi H, Landolfi S, et al. 2013. Brush border myosin Ia inactivation in gastric but not endometrial tumors. Int J Cancer 132(8):1790-1799.
85. McConnell RE, Tyska MJ. 2007. Myosin-1a powers the sliding of apical membrane along microvillar actin bundles. J Cell Biol 177(4):671-681.
86. McConnell RE, Tyska MJ. 2010. Leveraging the membrane-cytoskeleton interface with myosin-1. Trends Cell Biol 20(7):418-426.
87. Mele C, Iatropoulos P, Donadelli R, Calabria A, Maranta R, Cassis P, Buelli S, Tomasoni S, Piras R, Krendel M, et al. 2011. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med 365(4):295-306.
88. Menke V, Van Zoest KP, Moons LM, Pot RG, Siersema PD, Kuipers EJ, Kusters JG. 2012. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma. Scand J Gastroenterol 47(12):1422-1428.
89. Michael M, Yap AS. 2013. The regulation and functional impact of actin assembly at cadherin cell-cell adhesions. Semin Cell Dev Biol 24(4):298-307.
90. Mierke CT. 2013. Physical break-down of the classical view on cancer cell invasion and metastasis. Eur J Cell Biol 92(3):89-104.
91. Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, Franke L, van't Slot R, van Belzen MJ, Lavrijsen IC, et al. 2005. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 37(12):1341-1344.
92. Mooseker MS, Coleman TR. 1989. The 110-kD protein-calmodulin complex of the intestinal microvillus (brush border myosin I) is a mechanoenzyme. J Cell Biol 108(6):2395-2400.
93. Muller RT, Honnert U, Reinhard J, Bahler M. 1997. The rat myosin myr 5 is a GTPase-activating protein for Rho in vivo: essential role of arginine 1695. Mol Biol Cell 8(10):2039-2053.
94. Nakano T, Tani M, Nishioka M, Kohno T, Otsuka A, Ohwada S, Yokota J. 2005. Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer. Genes Chromosomes Cancer 43(2):162-171.
95. Naumov GN, Akslen LA, Folkman J. 2006. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5(16):1779-1787.
96. Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A, et al. 2002. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Proc Natl Acad Sci USA 99(19):12269-12274.
97. O'Connell CB, Tyska MJ, Mooseker MS. 2007. Myosin at work: motor adaptations for a variety of cellular functions. Biochim Biophys Acta 1773(5):615-630.
98. Odronitz F, Kollmar M. 2007. Drawing the tree of eukaryotic life based on the analysis of 2, 269 manually annotated myosins from 328 species. Genome Biol 8(9):R196.
99. Olivier M, Hollstein M, Hainaut P. 2010. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2(1):a001008.
100. Omelchenko T, Hall A. 2012. Myosin-IXA regulates collective epithelial cell migration by targeting RhoGAP activity to cell-cell junctions. Curr Biol 22(4):278-288.
101. Ostap EM. 2008. Tropomyosins as discriminators of myosin function. Adv Exp Med Biol 644:273-282.
102. Ouderkirk JL, Krendel M. 2014. Myosin 1e is a component of the invadosome core that contributes to regulation of invadosome dynamics. Exp Cell Res 322(2):265-276.
103. Patino-Lopez G, Aravind L, Dong X, Kruhlak MJ, Ostap EM, Shaw S. 2010. Myosin 1G is an abundant class I myosin in lymphocytes whose localization at the plasma membrane depends on its ancient divergent pleckstrin homology (PH) domain (Myo1PH). J Biol Chem 285(12):8675-8686.
104. Pi X, Ren R, Kelley R, Zhang C, Moser M, Bohil AB, Divito M, Cheney RE, Patterson C. 2007. Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors. J Cell Biol 179(7):1569-1582.
105. Pollard LW, Lord M. 2014. Getting myosin-V on the right track: tropomyosin sorts transport in yeast. Bioarchitecture 4(1):35-38.
106. Post PL, Bokoch GM, Mooseker MS. 1998. Human myosin-IXb is a mechanochemically active motor and a GAP for rho. J Cell Sci 111(Pt 7):941-950.
107. Pruyne D. 2008. Tropomyosin function in yeast. Adv Exp Med Biol 644:168-186.
108. Puri C, Chibalina MV, Arden SD, Kruppa AJ, Kendrick-Jones J, Buss F. 2010. Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis. Oncogene 29(2):188-200.
109. Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE, Huang DC, Strasser A. 2001. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 293(5536):1829-1832.
110. Rakha EA, Reis-Filho JS, Ellis IO. 2008. Basal-like breast cancer: a critical review. J Clin Oncol 26(15):2568-2581.
111. Richards TA, Cavalier-Smith T. 2005. Myosin domain evolution and the primary divergence of eukaryotes. Nature 436(7054):1113-1118.
112. Rogers MS, Strehler EE. 2001. The tumor-sensitive calmodulin-like protein is a specific light chain of human unconventional myosin X. J Biol Chem 276(15):12182-12189.
113. Royer C, Lu X. 2011. Epithelial cell polarity: a major gatekeeper against cancer? Cell Death Differ 18(9):1470-1477.
114. Sahai E. 2005. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15(1):87-96.
115. Sandquist JC, Swenson KI, Demali KA, Burridge K, Means AR. 2006. Rho kinase differentially regulates phosphorylation of nonmuscle myosin II isoforms A and B during cell rounding and migration. J Biol Chem 281(47):35873-35883.
116. Schiller HB, Friedel CC, Boulegue C, Fassler R. 2011. Quantitative proteomics of the integrin adhesome show a myosin II-dependent recruitment of LIM domain proteins. EMBO Rep 12(3):259-266.
117. Schoumacher M, Goldman RD, Louvard D, Vignjevic DM. 2010. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol 189(3):541-556.
118. Schramek D, Sendoel A, Segal JP, Beronja S, Heller E, Oristian D, Reva B, Fuchs E. 2014. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. Science 343(6168):309-313.
119. Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, et al. 2009. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 459(7250):1085-1090.
120. Shibue T, Brooks MW, Inan MF, Reinhardt F, Weinberg RA. 2012. The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. Cancer Discov 2(8):706-721.
121. Sibony-Benyamini H, Gil-Henn H. 2012. Invadopodia: the leading force. Eur J Cell Biol 91(11-12):896-901.
122. Skowron JF, Bement WM, Mooseker MS. 1998. Human brush border myosin-I and myosin-Ic expression in human intestine and Caco-2BBe cells. Cell Motil Cytoskeleton 41(4):308-324.
123. Slany RK. 2009. The molecular biology of mixed lineage leukemia. Haematologica 94(7):984-993.
124. Sousa AD, Cheney RE. 2005. Myosin-X: a molecular motor at the cell's fingertips. Trends Cell Biol 15(10):533-539.
125. Stark BC, Sladewski TE, Pollard LW, Lord M. 2010. Tropomyosin and myosin-II cellular levels promote actomyosin ring assembly in fission yeast. Mol Biol Cell 21(6):989-1000.
126. Szent-Gyorgyi AG. 2004. The early history of the biochemistry of muscle contraction. J Gen Physiol 123(6):631-641.
127. Taft MH, Behrmann E, Munske-Weidemann LC, Thiel C, Raunser S, Manstein DJ. 2013. Functional characterization of human myosin-18A and its interaction with F-actin and GOLPH3. J Biol Chem 288(42):30029-30041.
128. Taki T, Akiyama M, Saito S, Ono R, Taniwaki M, Kato Y, Yuza Y, Eto Y, Hayashi Y. 2005. The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22. Oncogene 24(33):5191-5197.
129. Teng MW, Swann JB, Koebel CM, Schreiber RD, Smyth MJ. 2008. Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol 84(4):988-993.
130. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442-454.
131. Tiwari A, Jung JJ, Inamdar SM, Nihalani D, Choudhury A. 2013. The myosin motor Myo1c is required for VEGFR2 delivery to the cell surface and for angiogenic signaling. Am J Physiol Heart Circ Physiol 304(5):H687-H696.
132. Tojkander S, Gateva G, Schevzov G, Hotulainen P, Naumanen P, Martin C, Gunning PW, Lappalainen P. 2011. A molecular pathway for myosin II recruitment to stress fibers. Curr Biol 21(7):539-550.
133. Tokuo H, Coluccio LM. 2013. Myosin-1c regulates the dynamic stability of E-cadherin-based cell-cell contacts in polarized Madin-Darby canine kidney cells. Mol Biol Cell 24(18):2820-2833.
134. Tyska MJ, Mooseker MS. 2002. MYO1A (brush border myosin I) dynamics in the brush border of LLC-PK1-CL4 cells. Biophys J 82(4):1869-1883.
135. Tyska MJ, Mooseker MS. 2004. A role for myosin-1A in the localization of a brush border disaccharidase. J Cell Biol 165(3):395-405.
136. Tyska MJ, Warshaw DM. 2002. The myosin power stroke. Cell Motil Cytoskeleton 51(1):1-15.
137. Tyska MJ, Mackey AT, Huang JD, Copeland NG, Jenkins NA, Mooseker MS. 2005. Myosin-1a is critical for normal brush border structure and composition. Mol Biol Cell 16(5):2443-2457.
138. van Bodegraven AA, Curley CR, Hunt KA, Monsuur AJ, Linskens RK, Onnie CM, Crusius JB, Annese V, Latiano A, Silverberg MS, et al. 2006. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 131(6):1768-1774.
139. van Diepen MT, Parsons M, Downes CP, Leslie NR, Hindges R, Eickholt BJ. 2009. MyosinV controls PTEN function and neuronal cell size. Nat Cell Biol 11(10):1191-1196.
140. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. 2009. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 10(11):778-790.
141. Vicente-Manzanares M, Zareno J, Whitmore L, Choi CK, Horwitz AF. 2007. Regulation of protrusion, adhesion dynamics, and polarity by myosins IIA and IIB in migrating cells. J Cell Biol 176(5):573-580.
142. Vindin H, Gunning P. 2013. Cytoskeletal tropomyosins: choreographers of actin filament functional diversity. J Muscle Res Cell Motil 34(3-4):261-274.
143. Waldner MJ, Neurath MF. 2009. Colitis-associated cancer: the role of T cells in tumor development. Semin Immunopathol 31(2):249-256.
144. Walz C, Chase A, Schoch C, Weisser A, Schlegel F, Hochhaus A, Fuchs R, Schmitt-Graff A, Hehlmann R, Cross NC, et al. 2005. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1. Leukemia 19(6):1005-1009.
145. Wang A, Ma X, Conti MA, Adelstein RS. 2011. Distinct and redundant roles of the non-muscle myosin II isoforms and functional domains. Biochem Soc Trans 39(5):1131-1135.
146. Wang CL, Coluccio LM. 2010. New insights into the regulation of the actin cytoskeleton by tropomyosin. Int Rev Cell Mol Biol 281:91-128.
147. Williams DS, Lopes VS. 2011. The many different cellular functions of MYO7A in the retina. Biochem Soc Trans 39(5):1207-1210.
148. Wirth JA, Jensen KA, Post PL, Bement WM, Mooseker MS. 1996. Human myosin-IXb, an unconventional myosin with a chimerin-like rho/rac GTPase-activating protein domain in its tail. J Cell Sci 109(Pt 3):653-661.
149. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P. 2007. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 9(8):893-904.
150. Woolner S, Bement WM. 2009. Unconventional myosins acting unconventionally. Trends Cell Biol 19(6):245-252.
151. Yanaihara N, Nishioka M, Kohno T, Otsuka A, Okamoto A, Ochiai K, Tanaka T, Yokota J. 2004. Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer. Int J Cancer 112(1):150-154.
152. Yang C, Svitkina T. 2011. Filopodia initiation: focus on the Arp2/3 complex and formins. Cell Adh Migr 5(5):402-408.
153. Yoshida H, Cheng W, Hung J, Montell D, Geisbrecht E, Rosen D, Liu J, Naora H. 2004. Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer. Proc Natl Acad Sci USA 101(21):8144-8149.
154. Zhang H, Berg JS, Li Z, Wang Y, Lang P, Sousa AD, Bhaskar A, Cheney RE, Stromblad S. 2004. Myosin-X provides a motor-based link between integrins and the cytoskeleton. Nat Cell Biol 6(6):523-531.